Recruiting Ankylosing Spondylitis Studies in Spokane
Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease
This Phase 2a study aims to evaluate the efficacy, safety and tolerability of NMD670 vs placebo administered twice a day (BID) for 21 days in ambulatory adult patients with Charcot-Marie-Tooth disease...
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
The primary objective of this study is to determine the effects of semaglutide on kidney oxygenation and function in type 1 diabetes. The secondary objective is to determine the glycemic effects and s...
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
This Phase 2a, multicenter, randomized, 12-week double-blind, placebo-controlled, parallel-group study, followed by an OLE, is designed to evaluate the safety, tolerability, and pharmacodynamic effect...
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
This study is to evaluate the safety, the systemic exposure of halobetasol propionate (HP), and the hypothalamic-pituitary-adrenal (HPA) axis suppression potential for topically applied IDP-122 lotion...
About Ankylosing Spondylitis Clinical Trials in Spokane
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Spokane, WASHINGTON. These studies are seeking a combined 235 participants. Research is being sponsored by NMD Pharma A/S, University of Washington, Denali Therapeutics Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Spokane — FAQ
Are there ankylosing spondylitis clinical trials in Spokane?
Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Spokane, WASHINGTON. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Spokane?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Spokane research site will contact you about next steps.
Are clinical trials in Spokane free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Spokane studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 4 active trials in Spokane are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov